Decreased GTPase activity of K- ras mutants deriving from human functional adrenocortical tumours
2000

K-ras Mutants in Adrenocortical Tumors

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): Lin S-R, Hsu C-H, Tsai J-H, Wang J-Y, Hsieh T-J, Wu C-H

Primary Institution: Kaohsiung Medical College

Hypothesis

Are the mutation hot spots in human adrenocortical tumors associated with activation of the K-Ras oncogene?

Conclusion

Mutations at specific hot spots in the K-Ras gene are associated with the activation of the K-Ras oncogene in adrenocortical tumors.

Supporting Evidence

  • Seven out of 15 patients with adrenocortical tumors contained K-ras gene mutation.
  • The mutation type was a multiple-site mutation at codons 15, 16, 18, and 31.
  • The wild-type K-Ras protein exhibits about ten times higher intrinsic GTPase activity than the mutant K-Ras protein.

Takeaway

This study found that certain changes in a gene called K-Ras are linked to tumors in the adrenal glands, but more research is needed to understand how they cause cancer.

Methodology

Mutant K-Ras genes were cloned from tumor tissues and expressed in E. coli to measure their GTPase activity.

Limitations

Further experiments are needed to prove the association of K-Ras mutations with tumors.

Participant Demographics

Patients with adrenocortical tumors.

Digital Object Identifier (DOI)

10.1054/bjoc.1999.1039

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication